CMS Is Regulating the Wrong Thing — Here’s How to Fix Remote Patient Monitoring Without Losing the Care
Why should Medicare determine who is qualified to provide remote monitoring by asking who employs the nurse, rather than who is accountable for the patient's care?
How Innovation in BTK Inhibitor Development Is Improving Treatment Outcomes
BTK inhibitor has become an important treatment option for certain B-cell malignancies.
Mental Health Care Was Never Built for Everyone — AI Won’t Fix That
Companies aren't slowing down to ask if AI is ready for mental health; they're racing to build it in. Encoding the same unexamined standards into these tools means repeating the systemic issues marginalized groups have lived with for far too long.
Midstream Health Snags $20M to Provide Health Systems More Financial Stability
Midstream's Series A round was led by Valtruis, and included participation from Andreessen Horowitz (a16z), Foundry and CommonSpirit Ventures.
Rare Disease Biotech Setara Starts Out With $90M and a Lead Drug in the Clinic
Setara Biosciences’ lead program is a potential treatment for the rare neuromuscular disorder Charcot-Marie-Tooth disease type 2C and the prevalent condition overactive bladder. This small molecule came from Actio Biosciences, which was recently acquired by Jazz Pharmaceuticals.